EVH241220P12500
- 0.50
- -0.02-3.85%
Evolent Health Newsroom
Evolent Health Price Target Cut to $15.00/Share From $45.00 by JP Morgan
J.P. Morgan Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $15
High Quality 'SMID-cap' Stocks With Cyclical Exposure – MS
Evolent Health, Inc. (EVH): This Small-Cap Stock Is Ready To Explode
Oppenheimer Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $28
Evolent Health Is Maintained at Outperform by Oppenheimer
Oppenheimer Maintains Outperform on Evolent Health, Lowers Price Target to $28
Express News | Evolent Health Inc : Oppenheimer Cuts Target Price to $28 From $34
Evolent Health (NYSE:EVH) Seems To Use Debt Quite Sensibly
Engaged Capital Adds BlackLine, Exits Shake Shack, Others in Q3
Citi Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $21
Express News | Evolent Health Inc : Citigroup Cuts Target Price to $21 From $33
RBC Capital Maintains Evolent Health(EVH.US) With Buy Rating, Cuts Target Price to $20
Evolent Health Price Target Maintained With a $20.00/Share by RBC Capital
A Quick Look at Today's Ratings for Evolent Health(EVH.US), With a Forecast Between $19 to $36
RBC Capital Sticks to Its Buy Rating for Evolent Health (EVH)
Evolent Health Shares Are Trading Higher. Barclays Maintained an Overweight Rating on the Stock.
Express News | Evolent Health Shares Are Trading Higher. Barclays Maintained an Overweight Rating on the Stock
Evolent Health Is Maintained at Overweight by Barclays
Evolent Health Analyst Ratings